Dr. Lynch is an immunologist/virologist whose work focuses on the interactions between virus and antibody during early infection with an emphasis on development and ontogeny of virus-specific antibody lineages. She trained at the Vaccine Research Center at the NIH as post-doctoral fellow in Dr. John Mascola’s lab where her research focused on antibody and virus lineage development in individuals who develop broadly neutralizing antibody responses against HIV-1. Her independent laboratory investigates how HIV-1 escapes from broadly neutralizing antibodies, and how to use this information to inform cure strategies. The lab is currently analyzing the neutralization sensitivity of re-activated reservoir virus from individuals on anti-retroviral therapy with an aim to inform personalized HIV-1 treatment. Her lab also studies early antibody responses to HIV-1 infection and vaccination and how these responses are affected by the microbiome, as well as early responses to Zika infection and how these antibody responses may be shaped by prior flavivirus infection